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Studies on the cell proliferation kinetics of psoriatic 
e pidermal cells are presented and the results compared 
to similar studies for normal epidermis. The short 36-h 
duration of the psoriatic cell cycle (Tc) is confirmed with 
the first double-peaked fraction of labeled mitoses 
(F LM) curve in human subjects. The growth fraction of 
psoriasis using two experimental techniques approxi-
mates 100% within 36 h, confirming the ra.pid T c found 
by the FLM method. 
The cell kinetic basis for the pathophysiology of pso-
riasis consists of at least 3 proliferative abnormalities 
i n comparison to normal epidermis. By far the largest 
alteration is the shortening of the T c from 311 to 36 h. 
There is also a doubling of the proliferative cell popu-
lation in psoriasis from 27,000 to 52,000 cells/rum and 
an increase in the growth fraction from 60% to 100%. 
As a consequence of these a bnormalities the psoriatic 
epidermis produces 35,000 cells/day from a prolifera-
tive compartment of 52 ,000 cells/mm2 surface area. This 
is a 28-fold greater production of cells than the 1,246 
cells/day produced in normal epidermis. The biochemi-
cal or control factors leading to these kinetic differences 
continue to remain elusive. 
E ver s ince t he concept of psoriasis as a hyperplastic epider-
m a l disease was developed by Va n Scott a nd Eke! [1] m a n y 
studies have attempted t o define a nd quantitate t his process. 
The hyperplastic component of psoriasis has generally been 
exa mined in contras t to t he normal epidermis , thereby requir-
ing comparable data for both t issues. The major questions t hat 
have been asked are: (1) D o psoriatic and normal epidermal 
c e lls prolifera te at the same ra te , i.e. , do they have t he sam e 
c ell cycle para meters? (2) Are t he growth fractions s imilar in 
t h e proliferat ive compa rtments of the two tissues? (3) Can cell 
c ycle and growth fraction pa ra meters a s measures o f cell pro -
life ration be related to independent measurements of tra nsit 
tim es a nd cell popula tions in t he two tissues? 
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SA: epidermal surface area 
T c: duration of germinative cell cycle 
t.,: duration of G2 phase 
t, : duration of mitotic phase 
t,: duration of DNA synthesis phase 
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In previous reports from t his laboratory t he cell cycle time 
(Tc) of psoriatic epidermal cells was found to be 37.5 h us ing a 
part ia lly indirect technique, t he stage-duration method, which 
combines data from t he fraction of labeled mitoses (FLM) 
curve a nd the labeling index (LI) [2]. Ot her repor ts have 
suggested T c ranging from 33-114 h [3-6]. 
The work presented in t his report confirms t he rapid cell 
cycle duration o f psoria tic cells using t he classical direct method 
of a double-peaked FLM curve and the measuremen t of. t he 
growth fraction in p soriasis. The cell cycle data so den ved 
provide evidence t hat psoriatic cells proliferate approxi~ate~y 
8-fold faster t han d o norma l epidermal cells [7] . A kmetic 
m odel of epiderma l cell proliferation is p resented .for nor~al 
a nd p soriatic ep idermis t hat interrelates t hese kinet1c data w1t h 
t ra nsit t ime [8] and cell population data. 
METHODS 
Determination. ofT, by the FLM Method 
The direct measurement of the T, by t he FLM method requires a 
double-peaked curve of labeled mitoses (Fig 1). This study extends to 
70 h t he curve obtained in a prior investigation [2) which uti lized biopsy 
specimens obtained from 8 patients at 3-h in tervals from 0-27 h (F~g 
2). Jn the present study 6 patients, over t he age of 40 wit? chrome 
steady-state plaque psoriasis, were injected in tralesionally wtth 0.1 ml 
[ 3H) thymidine (sp act = 1.9-6.0 Ci/ mM) in multiple sites. From each 
patient 4-mm biopsies were obtained sequentially at 3- to 5-h in tervals 
over a period of 27-70 h after injections. The range of 27-70 h ~as 
chosen based on t he estimated T, of 37.5 h previously found wluch 
would predict t hat the second peak should occur about 37 h after the 
first peak which was at 9 h [2]. The specimens were pr:pared for 
autoradiography as previously described. A mean of ~9 m1t~ses was 
counted from each specimen and the values for each t tme pomt ~ere 
averaged. T he FLM values from 27- to 70-h samples were combmed 
with t he original FLM curve to produce a composite double-peaked 
FLM curve that is hand drawn and comparable to our prevwus studies. 
The distance between the 2 peaks (in hours) is the direct measurement 
of cell cycle duration and represents the mean t ime necessary fo r the 
labeled cohort of cells to go from mi tosis to mitosis (Fig 1). 
Growth Fraction in. Psoriasis 
In 3 patients with psoriasis [3H]thym idine was injected 1-4 times at 
12- h in tervals in to t he same sites intralesionally. One hour after t he 
last injection, biopsies of the sites were obtaine~ ~or aut?radiography · 
In control sites of psorias is, normal saline was mJect;ed mtrade:mally 
at one or more of t he first 3 t ime points fo llowed by [ H] thymtdme for 
the last injection. One hour after t he [3H] thymidine injections the s1tes 
were biopsied. LI were counted in the proli fe rative compartment of 
psoriatic epidermis as defined previously, i.e., the lower 3-4 rows of t he 
epidermis which contained cells with a higher nuclear/cytoplasmiC ratw 
and mitoses [2]. 
Age-Distribution A nalysis of the Psoriatic Cell Cycle 
Duffill et al [ 4,9] have proposed t he incorporation of the age-
distribut ion of an epidermal cell population when determining its cell 
cycle kinetics. It was suggested that t he age-distribution in psoriasis 
may be exponential resembling a tumor since t here are frequently 3 or 
more rows of proli fe rat ive cells in psoriasis. In contrast, t he single layer 
of proli fe rative cells in small animal skin may have a distribut ion 
somewhere between the rectangular and exponent ial age-distribut ion 
depending on t he direction of the mitotic axes. T he exponential age-
distribut ion equation can be used to determine both t he t heoretical LI 
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FIG 1. Schematic diagram of hypothetical experimental FLM curve 
showing 2 waves of lr. beled mitoses. The first peak of labeled mitosis 
follows soon after a cohort of ce lls is labeled in the DNA synthesis 
phase by (3H]thymidjne. The second peak represents the initially 
labeled cell cohort when it next passes through the mitotic phase. The 
rectangular forms are t he idealized structure of an FLM curve if all 
ce lls behaved in absolute ly uniform manner without variations in their 
cell cycle co mponents. S ince experimentally the cycles of individual 
cells vary, the re is a damping of the curve, particularly the second peak. 
The duration of the S phase ( T, ) and cell cycle (Tel are obtained as 
indicated. 
Houra pool 3t-t thymidine Injection 
FIG 2. Composite FLM curve derived from data on 2 groups of 
patients. The first group (e) represents 8 patients studied from 0-27 
h [2]. The second group <•l from this study includes 6 patients studied 
from 27- 70 h. T c measured between t he two peaks is 36 h. SEM is 
indicated for each time point. 
and the growth fraction if the T c is obtained by the FLM method: 
G 
LI (experimental) F = ==-..:..::..:.:."-"-'-:c..:.::..c-'---'-
Ll (theoretical) 
LI (theor) = { exp[ t. ~~2] - 1} { exp[ t~2~:2 ]} 
LI (theor) = { exp[ 8·53!n
2] - 1} { exp[ 4·23!n
2 
]} 
LI (theor) = 0.187 (18.7%) 
(1) 
(2) 
where t. equals duration of DNA synthesis phase and t"'' equals duration 
of G2 phase. 
Quantitation of Germinative and Differentiated Cell Compartments 
in Psoriatic Epiderm~~ 
Four-millimeter punch biopsies were obtained from typical chronic 
steady-state psoriatic plaques in 3 patients. From microphotographs of 
6 sections from each patient the proliferative and differentiated cell 
Vol. 85, No.6 
populations were delineated as previously described for normal epider-
mis (2]. The nucleated proliferative and differentiated cells were 
counted and a measurement of t he overylying epidermal length was 
obtained with the results expressed as the mean number of cells/mm 
surface length. 
In order to obtain the total number of cells in each compartment/ 
mm2 surface area, a t hree-dimensional measurement of the epidermis 
is necessary using mean cell diameters. From microphotographs as 
above 30 vertical columns of cells were measured to obtain the mean 
cell diameters for each compartment [7] . Based on the average diameter 
and number of cells in each compartment the total number of cells/ 
compartment/mm2 epidermal surface area (SA) was calculated. 
RESULTS 
Determination of Cell Cycle Duration 
During the 27- to 70-h period the second peak is obtained 
with a maximum at 45 h after [3H]thymidine injections. The 
shape of the second peak, broader and lower, is comparable to 
most other human and animal studies, indicating some desyn-
chronization of the labeled cohort in each succeeding cycle. 
The mean Tc of the psoriatic epidermal cell is 36 h as deter-
mined by the distance between the 2 peaks (9-45 h) (Fig 2). 
The components of the cell cycle, tg,, t., t·~· and tm, are listed in 
Table I and were previously determined using the Quastler 
technique [2]. 
The FLM results from the 2 sets of psoriasis data were 
computer analyzed [10] by Dr. M. Mendelsohn (University of 
California, Livermore). The computer analysis (t., = 29.6 h, 
CV = 0.37; t. = 7.5, CV = 0.45; tg2 = 4.5, CV = 0.45; tm = 0.4, 
CV = 0.45; Tc = 42, CV = 0.28) is similar to the results found 
with the hand method (Table I) but a lso provides estimates of 
the variability of transit rates through the cell cycle or coeffi-
cient of variation (CV = standard deviation expressed as per-
centage of the mean) . The relatively small CV for the psoriatic 
Tc of 28% reflects a small difference in the rates at which cells 
move around the cell cycle [11] . With a SD of 10 h from the 
computer analysis, a major proportion of cells will have a Tc 
that may range from 26-46 h. 
Growth Fraction in Psoriasis 
With repeated injections of [3H )thymidine at each sequential 
t ime point there is an increase in the LI that approximates 90-
100% in the 36-h specimens (Figs 3, 4). The increasing LI 
reflects labeled daughter cells of previously labeled S phase 
cells that have divided, as well as labeling of new cells that 
have entered the S phase for the first time during the time 
periods of additional [3H]thymidine exposure. In addition la-
beled cells are found throughout the thickness of the differen · 
tiated cell compartment and just up to the stratum corneum 
layer, indicating continuous upward movement of the labeled 
cells. A transit time of 1.5-2.0 days is confirmed in these 
specimens [8) . Control specimens with saline injections fol-
lowed by [3H)thymidine show approximately 20-30% labeling, 
indicating only a small Koebner-like stimulation of the LI at 
the latter time points. 
Age Distribution Analysis of the Psoriatic Cell Cycle 
Using the experimentally determined values of Tc = 36 h, 
t. = 8.5 h, and Tg2 = 4.2 h (the values t. and tg2 are obtained 
from the first FLM peak [2]), Eq 1 and 2 are solved for the 
theoretical LI and growth fraction (GF). The theoretical LI is 
18.7% which is similar to the experimental values obtained by 
TABLE I. Summary of the cell cycle and its components for normal 
and psoriatic epiderm~~ 
Normal 
Psoriatic 
t. 
14 
8.5 
Duration (h) 
10 1 286 
4 0.3 23 
T. 
311 
36 
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FIG 3. Photomicrographs (x 250) from growth fraction study. A, 
Same site of psoriasis injected with 4 intradermal doses of [3H]thymi-
dine at 12- h intervals with biopsy 1 h after last dose. Approximately 
90% of proliferative cells are labeled. B, Control site with 3 saline 
injections at 12-h intervals followed by [3H] thymidine. 
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FIG 4. Growth fraction curve using 1-4 intermittent doses of intra-
dermal ["H]thymidine (T) at 12-h intervals in same sites. Control 
(lower line) used saline (S) injections prior to last injection of 
[ 3 H] thymidine, i.e., at the 24-h point, 3 injections of [3H]thymidine 
and/or saline had been given. 
Weinstein and Frost [2] of 16.2% (uncorrected) and 22.7 % 
(corrected) and 21.2% by Gelfant [12). Depending on which 
experimental LI is used, the GF calculated from Eq 1 ranges 
from 87- 121%, or essentially the same as the experimentally 
determined GF of 100%. 
Quantitation of Germinative and Differentiated Cells 
In psoriatic epidermis the number of viable nucleated cells 
in each section was obtained from 7 sections in each of 3 
patients. After extrapolation to 1 rom surface length, the ger-
minative and differentiated cell counts were 608 ± 127 (SD) 
cells/rom and 870 ± 116 cells/rom, respectively (Fig 5). The 
mean cell diameters for germinative and differentiated cells 
were 11.6 ± 1.0 and 18.4 ± 6.1 /-LID, respectively. To determine 
the number of germinative cells/mm2 SA, the number of ger-
minative cells in each 1 rom-long section (608) was multiplied 
by the number of sections underlying 1 mm2 of surface area. 
Since the average germinative cell diameter was 11.6 /-LID , there 
would be 86 sections/mm2 SA (each 11.6 I-LID thick). The total 
number of germinative cells in psoriasis calculates to be 52,000 
cells/mm2 SA. In a similar manner the differentiated cell com-
partment contains 47,000 cells/mm2 SA (870 cells x 54 sections 
( 18.41-Lm thick)). The total viable cell population of the psoriatic 
epidermis is 99,000 cells/mm2 SA. 
CEU,.S/1 nvn 2 SlffACE AREA 
47,000 DlffO<...u.led 
52,000 Prolt!Ototlve 
oo,ooo Toto! c-
FIG 5. Psoriatic cell populations in proliferative and differentiated 
compartments under 1 mm surface length and 1 mm2 surface area. 
Average width of cells is given in microns. 
DISCUSSION 
Extensive evidence has accumulated to indicate that the 
hyperproliferative activity of the epidermal cells is a major 
pathophysiologic component of psoriasis [1-4,6,8,12-15]. The 
foundation of cytokinetics today is based on the FLM method 
[ll] which is the most commonly used technique for determin-
ing Tc and its components t., tg,, and tm. If the FLM method is 
used for a limited time span providing only the first peak, then 
it must be integrated with other information, i.e., the Ll and 
GF, to obtain the Tc. This is considered an indirect technique, 
generally referred to as the stage-duration method, which has 
been used in the past by others including ourselves fo~ ~eas­
uring the kinetics of psoriasis and other tissues. The mdire~t 
methods to measure cell proliferation include flash LI, gram 
counts, and GF determinations. Difficulties with these methods 
are discussed below and by Wright [11). If data for _the FLM 
method can be obtained over a long enough span of time to get 
2 or more peaks in the FLM curve, then the duration of Tc_can 
be measured directly. This is by far the preferred metho~ smce 
it avoids many variables and assumptions inherent m the 
indirect methods. 
The major emphasis in this study is to obtain a second peak 
in the FLM curve which allows a direct measurement of the 
time required for a cohort of cells to move through a com~lete 
cell cycle from mitosis to mitosis (Fig 1). The Tc of36 h obtamed 
from the FLM curve confirms the previously calculated value 
of 37.5 h found by the stage-duration method (2]. The calcula-
tion of that value based on the information then available used 
a "corrected" LI of 22.7%, at. of 8.5 h, and assumed a GF of 
100%. Each of these values can be examined in retrospect more 
critically in light of newer information_ from_ this and. oth~r 
recent reports. The LI for psoriatic epJdermJ~ has v~ned m 
several studies from 10-25% [2-4,12,13] depending on different 
experimental criteria including the definition of the cell popu-
lation to be counted in vitro vs in vivo, amounts of isotope 
used, autoradiographic emulsions, and exposure ti~es [14]. 
Using techniques similar to ours, except for a~ autoradiography 
exposure time 2-3 times longer, Gelfant obtamed a LI of 21.2% 
[12] which is comparable to our "corrected" LI of 22.7%. An 
absolute LI of approximately 20% is further substantiated by 
the age-distribution analysis presented above which gives a 
theoretical LI of 18.7%. 
The second value used in our original Tc calculations of 
psoriasis, a t. of 8.5 h from the first FLM peak, was subse-
quently confirmed with FLM derived t . of 9.8 h and 7.7 h, 
respectively [3,4], indicating a consistency for this particular 
cell kinetic parameter. 
While the double-peaked FLM curve has been used in many 
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animal experiments, this is the first study in any human tissue 
to our knowledge that has been able to obtain a double-peaked 
curve in vivo. Single-peaked FLM curves in humans have been 
obtained to a limited extent in hematopoietic tissues, gastroin-
testinal tract epithelium, skin , and selected tumors. The diffi-
culties in fully utilizing the FLM technique are (1) giving 
patients, particularly with benign diseases, the large amount of 
["H]thymidine i.v. (5- 10 mCi) required, and (2) accessibility of 
the tissue to continued sampling at 3- to 6-h intervals over 
several days. The skin and lesions therein have permitted 
relatively easy accessibility at least for the first peak exteniling 
over 24-30 h and the intradermal use of small amounts of [3H] 
thymidine (5 J.LCi) in each site have minimized isotope exposure. 
Obtaining a second peak in the same patient would require an 
excessive number of specimens in a given subject, particularly 
if there is a prolonged T ., with the second peak several days 
after the first. The normal epidermis, with a T., of approxi-
mately 13 days [7], would be ilifficult to study in human subjects 
[15]. Since previous research on psoriasis had suggested a 
shortened T ., of 37 h, the second peak could be determined with 
a limited number of biopsies in each of the subjects. Only one 
other double-peaked FLM curve has been reported in skin 
(mouse) which gives a well-defined second peak and a relatively 
long Tc of about 100 h [16] . 
The proliferative cell kinetics of normal and psoriatic cells 
are summarized in Table I. The T., in normal epidermis of 311 
h was obtained by indirect calculations using at. from a single-
peaked FLM curve, a LI, and a GF from a continuous labeling 
experiment in vivo [7] . Based on these calculations the normal 
epidermal T ., is approximately 8-fold longer than the Tc of 
psoriatic cells (311 vs 36 h). 
Two other general approaches to the experimental determi-
nation of psoriatic cell cycle kinetics are found in the literature: 
(a) double-labeling techniques in vitro, and (b) [3H ]thymiiline 
grain counts Lo measure DNA synthesis rates [15]. Both meth-
ods suffer for various technical reasons including: (1) loss of 
physiologic conditions by being in vitro experiments; (2) inad-
equate quantitative differences experimentally; and (3) in ex-
periments to obtain grain counts there is an unwarranted, if 
not unlikely, assumption that normal and psoriatic cells are 
the same physiologically and biochemically. In the latter case 
it is probable that there are significant differences in precursor 
nucleotide pool sizes, critical enzyme levels, and certainly local 
blood flow conditions that can lead to spurious results [7,11]. 
The direct methods used in the current study avoid the poten-
tial errors suggested above. 
Much of the controversy surrounding psoriasis proliferation 
kinetics stems from observations that have suggested a prolon-
gation oft. in psoriatic cells compared to normal [5,17]. These 
studies have used indirect methods described above to obtain a 
t . in psoriasis of 14-20 h [5,18] which contrasts markedly to 
the direct FLM-derived much shorter t. values of 7.7, 8.5, and 
9.8 h [2- 4]. The prolonged t. for psoriasis found by these 
investigators [5,17] has led to calculations of longer cell cycle 
times ranging from 114-200 h and the conclusion that there is 
little or no difference in the Tc of normal and psoriatic epider-
mal cells [19,20]. We do not believe that the evidence for a 
prolonged t. and Tc in psoriasis based on the available infor-
mation with double-labeling techniques is valid when compared 
to the weight of evidence for a shortened Tc obtained by ilirect 
methods using FLM measurements, cell population counts, 
transit times, and GF information. 
Growth Fraction 
The problem of obtaining GF in human skin and other tissues 
is even more difficult than for FLM curves because of the large 
amount of isotope that must continually (or intermittently) be 
given to the subjects, as well as the number and accessibility of 
samples. In psoriasis, however, 3 techniques have permitted an 
approach to estimate that its GF approximates 100%. In an 
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earlier study, methotrexate over 36 h followed by [3H]thymiiline 
intradermally showed that the entire proliferative population 
of psoriasis was labeled, suggesting a GF of 100% [21] . 
In the current study the more classical technique using [3H ) 
thymiiline in intermittent doses over the putative Tc produces 
a curve (Fig 4) that reaches 90-100%, indicating that all the 
cells in the proliferative compartment (the lower 2-4 rows) are 
in a proliferating mode without significant numbers of Go 
(nonproliferating) cells in that compartment. While it would 
have been preferable to use i.v. [3H ]thymidine for a study like 
this, the flatness of the control curve using repeated saline 
injections into psoriatic plaques indicates that the "trauma" of 
injections does not appreciably affect this cell proliferation 
parameter. It does suggest that the psoriatic cell is proliferating 
at its maximum rate and cannot be further stimulated by a 
Koebner-like insult. 
Based on a mathematical approach to the age-ilistribution of 
cells in psoriasis [9), the GF ranges from 87-121% which 
confirms the direct approach values to the GF described above. 
The GF concept with respect to cancer chemotherapy is con-
cerned with the relative homogeneity of tumor cells in a prolif-
erative phase (rather than in a G0 resting phase) susceptible to 
the chemotherapeutic drugs being used. The approximate 100% 
GF in psoriasis suggests relative cell homogeneity with respect 
to cell kinetics and that all the cells might therefore be suscep-
tible to an appropriate therapeutic modality such as is seen 
with methotrexate. 
In contrast to psoriasis, the GF in normal epidermis is 
approximately 60% [7,12] and thus must increase to 100% in 
the transformation of "normal" (uninvolved epidermis) to pso-
riatic epidermis. It has previously been hypothesized that there 
is a small (incorrectly stated as "large" in [7]) GF in normal 
epidermis and that psoriasis results entirely from an expansion 
of the GF to 100% without changes in the Tc [19,20]. Since 
there is an 8-fold ilifference in the Tc of normal and psoriatic 
epidermis and less than a 2-fold difference in GF, the above 
hypothesis cannot be correct. 
Kinetic Model for Normal and Psoriatic Epidermis 
A kinetic model for psoriasis can be developed for comparison 
to a similar model of normal epidermis [7]. The model for 
psoriasis interrelates data from this study and transit time 
information on psoriasis previously published [8]. In the pres-
ent study the proliferative and differentiated cell populations 
of psoriasis were found to contain 52,000 and 4 7,000 cells/mm2 
SA, respectively (Fig 6) . Since the proliferative cell cycle (turn-
over time) is 1.5 days and the ilifferentiated transit time is 1. 75 
days (range 1.5-2.0 days), the birth or turnover rate/day of 
cells in each compartment calculates to be 35,000 (52,000/1.5) 
and 27,000 (47,000/1.75) cells, respectively. These values are 
reasonably similar and suggest that a kinetic homeostasis exists 
between birth and turnover rates of keratinocytes in these two 
compartments. Although the stratum corneum has a transit 
T.R. /d 
U17 
B.R. /d 
124ft 
1 mm 2 
NDUI 
17,000 
T.T . 12d 
27,000 
Tc 13d 
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DIFF ERENT IATED 
PROLIFERATIVE 
1 mm 2 
T.R./d N Olff 
27 ,000 
B.R./d 
36,000 
47,000 
T.T. 1.7&d 
No. c. 
52,000 
Tc 1.5d 
PSORIASIS 
FIG 6. Kinetics model for cell proliferation parameters of normal 
and psoriatic epidermis. B.R./d = birth rate/day; T.R./d = turnover 
(transit) rate/day; Nc.c. = number of germinative (proliferative) cells; 
Ndilf = number of differentiated (viable) cells. 
Dec. 1985 CELL KINETIC BASIS FOR PATHOPHYSIOLOGY OF PSORIASIS 583 
t ime of approximately 2 days [8,12] t here is no accurate infor-
mation on t he number of corneocytes in psoriasis to get a 
turnove r rate for that compartment. The calculations of kinetic 
equilibrium seen in t he cell turnover rates of each compartment 
u s ing independently derived cell counts and transit times fur-
t h e r confirms t he T c value of 36 h obtained by the FLM method. 
The kinetic data for normal epidermal cells [7] can be com-
pared to psoriatic cells in Fig 6. Several proliferat ive differences 
are readily apparent in the pathologic transition of "normal" 
to psoriatic cells. At the cellular level the hyperplasia of pso-
riasis appears to be mainly t he result of an 8-fold shorter T c 
which is acting on the second kinetic abnormality, a prolifera-
tive cell population that is doubled in the psoriatic epidermis. 
The t hird proliferative abberation is an expansion of t he normal 
GF from 60% to 100%. The sum total of these abnormalities 
causes the psoriatic epidermis to produce 28-fold more cells/ 
day than normal epidermis (birth rate of 35,000 cells/mm2 vs 
1,246 cells/mm2 in normal) . This enormous cellular hyperplasia 
must be responsible for the clinical presence of hyperkeratosis 
and extensive continual scaling. 
The overall turnover time of the psoriatic epidermis can be 
considered as the sum of the t urnover (cell cycle, transit) times 
for each of its cell compartments. The mean epidermal turnover 
time ofthe psoriatic lesion is approximately 5 If4 days, consisting 
of 1.5 days for t he proliferative compartment, 1. 75 days for the 
viable differentiated compa rt ment, and 2 days for t he stratum 
corneum. At t his time there is still too little informat ion avail-
able to understand the con t rolling or biochemical influences 
producing t he proliferative differences in normal and psoriatic 
epidermis. Potentially attractive areas of investigation would 
be t he reasons for t he la rge differences in cell cycle and S phase 
durations. 
The authors gratefully acknowledge the advice of Steven Scheinberg, 
M.D., Ph.D. for mathematical interpretations. 
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